{"id":"W2619722962","doi":"10.17925/ohr.2017.13.01.19","title":"Raising the Bar in Advanced Pancreatic Cancer","year":2017,"lang":"en","type":"article","venue":"touchREVIEWS in Oncology & Haematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Oxaliplatin; Irinotecan; Pancreatic cancer; Oncology; Internal medicine; Randomized controlled trial; Clinical trial; First line; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00208564,0.0002842653,0.002468301,0.000216966,0.0003366082,0.00001905459,0.0006934335,0.0004335336,0.001073256],"category_scores_gemma":[0.002912099,0.0001862019,0.0001492624,0.0001891839,0.001158913,0.0001291016,0.0002715249,0.001000005,0.0002787279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005265563,"about_ca_system_score_gemma":0.00101838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009733317,"about_ca_topic_score_gemma":0.004543114,"domain_scores_codex":[0.996587,0.0008161712,0.001008507,0.0005385213,0.000206397,0.0008433778],"domain_scores_gemma":[0.9967521,0.001217964,0.0004521031,0.001328978,0.00009894465,0.0001498904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004337923,0.0003090563,0.8401791,0.0003432436,0.00008306625,0.002473583,0.0006779017,0.00000455596,0.0003043417,0.002665997,0.001631899,0.1508935],"study_design_scores_gemma":[0.008094795,0.0007590376,0.7730352,0.001735496,0.0003784905,0.002623586,0.0003553965,0.0005730779,0.0001483217,0.00348695,0.2084613,0.0003482529],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9063982,0.02285967,0.00006640884,0.03059729,0.0004571098,0.001924105,0.000002745382,0.00002735578,0.03766711],"genre_scores_gemma":[0.9625898,0.03034054,0.001538673,0.002859035,0.0001495279,0.001268519,0.000005856697,0.00003239283,0.001215675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2068294,"threshold_uncertainty_score":0.9998399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1171455752535715,"score_gpt":0.475567786133746,"score_spread":0.3584222108801745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}